Immutep
IMMP
ATLANTA, GA – – (Globe Newswire – May 11, 2026) – – A shareholder class action lawsuit has been filed against Immutep Limited (“Immutep”) (NASDAQ: IMMP). The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose material adverse facts regarding the status and prospects of Immutep’s TACTI-004 trial.
If you purchased Immutep shares between March 24, 2025 and March 12, 2026, and experienced a loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/immutep/ for more information.
The deadline to ask the court to be appointed lead plaintiff in the case is July 6, 2026.
Registration Deadline
Lead Plaintiff Deadline Has Passed
July 6, 2026